CD28 and myocarditis: To facilitate the clinical translation of FAP.CAR-T cells in treatment of myocarditis, we constructed a CAR molecule targeting human FAP based on MO36 mAb clone by fusing its scFv fragment with human CD28 and CD3z endodomain (referred as hFAP.CAR, Figure 6A).